Abstract:Glioblastoma multiforme (GBM) is the most lethal glioma variant in the adult brain and among the deadliest of human cancers. Increasing evidence has shown that metabotropic glutamate receptor subtype 4 (mGluR4) expression may play roles in regulating the growth of neural stem cells as well as several cancer cell lines. Here, we investigated the effects of mGluR4 on the growth and apoptosis of the LN229 GBM cell line. Involvement of Gli-1, one of the key transcription factors in the sonic Hedgehog (SHH) signaling pathway, was further explored. In this study, mGluR4 was activated using selective agonist VU0155041; and gene-targeted siRNAs were used to generate loss of function of mGluR4 and Gli-1 in LN229 cells. The results demonstrated that LN229 cells expressed mGluR4 and the agonist VU0155041 decreased cell viability in a dose- and time-dependent manner. Activation of mGluR4 inhibited cyclin D1 expression, activated pro-caspase-8/9/3, and disrupted the balance of Bcl-2/Bax expression, which indicated cell cycle arrest and apoptosis of LN229 cells, respectively. Furthermore, Gli-1 expression was reduced by mGluR4 activation in LN229 cells, and downregulation of Gli-1 expression by gene-targeted siRNA resulted in both inhibition of cell proliferation and promotion of apoptosis. Moreover, VU0155041 treatment substantially blocked SHH-induced cyclin D1 expression and cell proliferation, while increasing TUNEL-positive cells and the activation of apoptosis-related proteins. We concluded that activation of mGluR4 expressed in LN229 cells could inhibit GBM cell growth by decreasing cell proliferation and promoting apoptosis. Further suppression of intracellular Gli-1 expression might be involved in the action of mGluR4 on cancer cells. Our study suggested a novel role of mGluR4, which might serve as a potential drug target for control of GBM cell growth.

Effect of Bone Morphogenetic Protein 4 in the Human Brain Glioma Cell Line U251.

Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application

Autophagy Contributes to ING4-induced Glioma Cell Death.

Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis with Inhibition of Gli-1 in Human Glioblastoma Cells.

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4

BMP4 induces a p21-dependent cell state shift in glioblastoma linking mesenchymal transition to senescence

BMP4 Promotes Hepatocellular Carcinoma Proliferation by Autophagy Activation Through JNK1-mediated Bcl-2 Phosphorylation

Bmp4 Enhances Hepatocellular Carcinoma Proliferation by Promoting Cell Cycle Progression Via Id2/Cdkn1b Signaling

BMP—4 Induced Proliferation and Oriented Differentiation of Rat Hepatic Oval Cells into Hepatocytes

BMP4 promotes the metastasis of gastric cancer by inducing epithelial-mesenchymal transition via Id1.

The Effect of RNA Interference-Mediated Down-Regulation of EphB4 on the Growth of Malignant Glioma Cell Line U251

Tumor and Stem Cell Biology BMP 4 Administration Induces Differentiation of CD 133 þ Hepatic Cancer Stem Cells , Blocking Their Contributions to Hepatocellular Carcinoma

Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway

Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells

Knockdown of SALL4 expression using RNA interference induces cell cycle arrest, enhances early apoptosis, inhibits invasion and increases chemosensitivity to temozolomide in U251 glioma cells

AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways

Effect of kinase PLK4 on the proliferation of glioma cells in vitro

Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling

Knockdown of EphB4 gene by small interference RNA inhibits proliferation of glioma cells in vitro

BRD4 Promotes Glioma Cell Stemness Via Enhancing Mir‐142‐5p‐mediated Activation of Wnt/β‐catenin Signaling